New research indicates that for Texas providers and patients, the 2016 Food and Drug Administration’s (FDA) new labeling for the abortion drug mifepristone increased access options and brought the proportion of medication abortions in the state into alignment with national data.
In 2002, just 2.4% of U.S. women using birth control were using long-acting reversible contraceptive (LARC) methods, such as the intrauterine device or the contraceptive implant. By 2014, about 14% of women using birth control reported LARC use.
Even though age limits for purchasing emergency contraception (EC) were removed five years ago, results of a recent survey of more than 700 Texas pharmacies found that 46.5% of drugstores still have an age restriction for buying the medication, and more than 50% require a consultation before medication purchase.
As restrictions of clinic access to abortion mount, some women may seek internet access to services. Research indicates that women seeking medication abortion drugs online choose to do so because of barriers to clinic access in states with and without restrictive abortion laws. The choice also can happen when women prefer to self-manage their abortion rather than receive clinical care.
Coding has become an essential skill for patient access, in light of the surge in claims denials occurring due to the switch to ICD-10. This article will discuss steps patient access can take to ensure correct coding.
Patient access leadership is sometimes omitted from planning discussions involving staffing, technology, and new service lines. This article discusses steps patient access can take to prevent problems with patient satisfaction.